Add BrightSurf on Google Email

Brigham and Women's Hospital


Research spotlight: improving the surveillance of medical product safety with the real-world evidence data enterprise

The Real-World Evidence Data Enterprise (RWE-DE) combines longitudinal electronic health records with insurance claims data to improve the validity of studies on medical products in clinical practice. This new infrastructure will enable the FDA to conduct studies using granular clinical information to identify medication safety issues.

SourceBrigham and Women's Hospital·JournalPharmacoepidemiology and Drug Safety·DateOct 31, 2024

Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity

A recent study found that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023, while rates of metabolic bariatric surgery dropped by one quarter. This shift in treatment options has implications for access to comprehensive multidisciplinary care for obesity.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·TypeObservational study·DateOct 25, 2024

Research spotlight: Investigating strategies to help clinicians and patients navigate prescription costs

Researchers found that co-payment cards can lower out-of-pocket costs for privately insured patients taking brand-name prescription drugs. Additionally, public assistance programs and direct-to-consumer pharmacies can provide affordable alternatives for uninsured individuals and those with Medicare Part D. The study suggests that clini...

SourceBrigham and Women's Hospital·JournalJAMA·TypeObservational study·DateOct 21, 2024

Study finds persistent infection could explain long COVID in some people

Researchers at Brigham and Women's Hospital found that people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood compared to those without long COVID symptoms. This persistent infection could explain some of the long COVID sufferers' symptoms, suggesting a potential treatment target.

SourceBrigham and Women's Hospital·JournalClinical Microbiology and Infection·DateOct 9, 2024

Brigham study finds older adults who experience a fall are at increased risk of dementia

Researchers from Brigham and Women's Hospital found that older adults who sustained a traumatic injury were more likely to be diagnosed with Alzheimer's disease and related dementias if they experienced falls. The study suggests that completing cognitive screenings in older patients after a fall could help detect dementia sooner.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·TypeData/statistical analysis·DateSep 30, 2024

Common brain network detected among veterans with traumatic brain injury could protect against PTSD

Researchers at Brigham and Women's Hospital have identified a specific brain circuit that may protect against post-traumatic stress disorder (PTSD) in veterans with traumatic brain injury. The study suggests using neurostimulation therapies on this circuit could treat PTSD, offering a new potential non-invasive treatment option.

SourceBrigham and Women's Hospital·JournalNature Neuroscience·TypeObservational study·DateSep 24, 2024

Research spotlight: Radiology test can be used to diagnose immune checkpoint inhibitor-associated acute kidney injury

F18-FDG PET-CT scans showed significantly higher levels of radioactively-labeled glucose in kidneys for patients with ICI-AKI compared to those with AKI from non-ICI causes. This suggests a potential non-invasive testing option for differentiating cause of AKI as being ICI-related vs. non-ICI-related.

SourceBrigham and Women's Hospital·JournalJournal of Clinical Investigation·DateSep 5, 2024

Brigham-led clinical trial finds finerenone reduces worsening heart failure and cardiovascular death

A randomized, placebo-controlled trial found finerenone improved outcomes in patients with heart failure and mildly reduced or preserved ejection fraction. The drug also showed benefits regardless of the ejection fraction and even in patients on other approved therapies.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 1, 2024

Brigham-led study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic

A recent study led by Brigham and Women's Hospital found that semaglutide reduced deaths from cardiovascular disease and infections, including COVID-19, in obese and overweight patients. The study involved over 17,000 participants and showed a 19% lower overall death rate compared to placebo.

SourceBrigham and Women's Hospital·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateAug 30, 2024

Brigham-led study estimates 1 in 7 Medicare beneficiaries with high body mass index may qualify for anti-obesity drug

A new study estimates that 1 in 7 Medicare beneficiaries with elevated body mass index (BMI) may qualify for semaglutide, a popular weight loss medication. The study found that maximum annual costs to Medicare could exceed $10 billion if different definitions of cardiovascular risk are considered.

SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateAug 26, 2024

Research study examines Alzheimer’s disease drug on tissue samples from people with Down syndrome

Researchers tested lecanemab, an anti-amyloid drug, on brain tissue samples from individuals with Down syndrome, finding it effectively targeted amyloid plaques but also bound to blood vessels. The study highlights the need for careful consideration of safety and potential hemorrhagic complications in people with Down syndrome.

SourceBrigham and Women's Hospital·JournalJAMA Neurology·TypeExperimental study·DateAug 19, 2024

Brigham study finds new program streamlined hospice transitions from the emergency department

A new program at Brigham and Women's Hospital has successfully streamlined hospice transitions for patients nearing the end of life, increasing transitions within 96 hours of ED arrival to 54.1 percent. The program uses AI algorithm, dedicated care management, and emergency department rounds to flag potential candidates and mobilize ho...

SourceBrigham and Women's Hospital·JournalJAMA Network Open·DateJul 8, 2024

Military service's hidden health toll: servicewomen and their families endure increased chronic pain

A new study reveals that military women and female family members face significantly higher risks of chronic pain, with those serving during periods of heightened combat deployments facing a 53% higher likelihood of developing the condition. The study also found associations between chronic pain, mental health, and socioeconomic status.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·TypeObservational study·DateJul 5, 2024

Research spotlight: Uncovering how a cellular miscommunication leads to cognitive impairment in female patients with Alzheimer’s disease

A study found that APOE4 impairs communication between immune cells, leading to cognitive decline in female Alzheimer's patients. The researchers identified a new subset of neutrophils interacting with microglia associated with cognitive impairment, which could be targeted for therapeutic intervention.

SourceBrigham and Women's Hospital·JournalNature Medicine·DateJul 3, 2024

Study finds innovative cuffless blood pressure device streamlines and enhances hypertension management

A study found that a cuffless wrist monitor provides hundreds of readings in days, enabling clinicians to determine cardiovascular risk and improve hypertension care. The device's continuous readings help confirm diagnosis and guide medication titration, potentially revolutionizing hypertension management.

SourceBrigham and Women's Hospital·JournalFrontiers in Medicine·TypeObservational study·DateJun 26, 2024

Nano-immunotherapy developed to improve lung cancer treatment

Researchers at Brigham and Women's Hospital have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer. The therapy shows promising results in cancer cells in the lab and in mouse lung tumor models, with potential applications for improving care...

SourceBrigham and Women's Hospital·JournalScience Advances·TypeExperimental study·DateJun 14, 2024

Researchers develop microneedle patch to reverse hair loss caused by autoimmune disease

A new microneedle patch has been developed to treat autoimmune disease alopecia areata by delivering immune regulators to affected skin areas, promoting lasting hair regrowth. The approach restores immune balance and resolves T cell attack on hair follicles, offering a potential long-term solution without compromising the immune system.

SourceBrigham and Women's Hospital·JournalAdvanced Materials·DateJun 6, 2024

Brigham researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity

A meta-analysis of 15 randomized studies found that patients taking GLP-1 medications experienced only mild differences in gastric emptying, delaying solid food by about 36 minutes. The findings suggest it may be safe to continue these medications before surgery without a high risk of aspiration.

SourceBrigham and Women's Hospital·JournalThe American Journal of Gastroenterology·TypeRandomized controlled/clinical trial·DateJun 4, 2024

New study finds people living with dementia who had surgery for hip fractures lived longer than those treated non-surgically

A new study by Brigham and Women's Hospital found that patients with dementia who underwent surgery for hip fractures experienced lower odds of death compared to those treated non-surgically. The benefit was seen in patients with head and neck of the femur fractures, but not in other locations.

SourceBrigham and Women's Hospital·JournalJAMA Network Open·DateMay 30, 2024

Study finds older adults hospitalized for heart failure had high risk of kidney complications

Researchers found that 6% of patients with heart failure progressed to dialysis within a year, highlighting the need for integrating heart and kidney care. The study emphasizes prioritizing kidney function assessment in all patients with heart failure and promoting systemic changes to manage both conditions simultaneously.

SourceBrigham and Women's Hospital·JournalJAMA Cardiology·TypeObservational study·DateMay 29, 2024

Brigham study finds eliminating race-based metrics improves prediction for COPD outcomes

A new study found that using race-neutral equations for lung function test interpretation accurately predicted risk of death and COPD flare-ups, especially for African Americans. The study suggests reclassifications can allow those most in need to gain eligibility for specialized treatments like lung transplant.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeObservational study·DateMay 21, 2024

Should your exercise goals be in minutes or steps? Study suggests they are equally beneficial

A study of 14,399 women found that both step-based and time-based exercise targets were associated with lower risks of early death and cardiovascular disease. The research suggests that individuals should choose a goal aligned with their personal preferences rather than focusing on specific metrics.

SourceBrigham and Women's Hospital·JournalJAMA Internal Medicine·TypeObservational study·DateMay 20, 2024

Researchers develop “game-changing” blood test for stroke detection

Researchers developed a game-changing blood test that can quickly and accurately identify large vessel occlusion strokes, which have the potential to bring life-saving care to patients globally. The test combines biomarkers with a clinical score to detect strokes with 93% specificity and 81% sensitivity.

SourceBrigham and Women's Hospital·JournalStroke Vascular and Interventional Neurology·TypeExperimental study·DateMay 17, 2024